Analyst picks & changes

Analyst picks & changes

Analyst picks & changes
CompanyBankAnalystCoverageOpinionWk chg5/20 cls
Arbutus Biopharma Corp. (NASDAQ:ABUS)Chardan CapitalMadhu KumarNewSell-6%$4.08
Kumar initiated coverage with a $3.25 target, saying competition to Arbutus' lead

Read the full 268 word article

How to gain access

Continue reading with a
two-week free trial.